Potential effectiveness of traditional Chinese medicine for cardiac syndrome X (CSX): A systematic review and meta-analysis

BMC Complementary and Alternative Medicine

Volumn 13, Issue , 2013, Pages

  Wang, Jia ying ^a   Xiao, Lu ^a   Chen, Jing ^a   Zhai, Jing bo ^a   Mu, Wei ^a   Mao, Jing yuan ^b   Shang, Hongcai ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b FIRST TEACHING HOSPITAL OF TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHINESE DRUG; ENDOSTATIN; ENDOTHELIN 1;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CHINESE MEDICINE; DRUG SAFETY; ELECTROCARDIOGRAM; EXERCISE INTENSITY; FEMALE; HUMAN; INFORMATION RETRIEVAL; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; OUTCOME ASSESSMENT; PUBLISHING; STOMACH PAIN; SYNDROME X; SYSTEMATIC REVIEW; THERAPY EFFECT; TREADMILL EXERCISE; TREATMENT DURATION;

DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; MICROVASCULAR ANGINA; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84874937842     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-13-62     Document Type: Article

References (47)

1. Gaetano Antonio Lanza GA, Crea F. Primary coronary microvascular dysfunction clinical presentation, pathophysiology, and management. Circulation 2010, 121:2317-2325. 10.1161/CIRCULATIONAHA.109.900191, 20516386.
2. Zipes DP, Libby P, Bonow RO. Braunwald's heart disease: a textbook of cardiovascular medicine 2008, Philadelphia: Saunders-Elsevier, 8.
3. Bi YF, Mao JY, Wang XL. Contemporary treatment of Western and Chinese medicine for cardiac syndrome X. Chin J Integr Med 2011, 17(4):314-320. 10.1007/s11655-011-0714-2, 21509677.
4. Di Monaco A, Lanza GA, Bruno I. Usefulness of impairment of cardiac adrenergic nerve function to predict outcome in patients with cardiac syndrome X. Am J Cardiol 2010, 106(12):1813-1818. 10.1016/j.amjcard.2010.07.052, 21126626.
5. Piegza M, Pudlo R, Badura-Brzoza K, Hese RT. Cardiac syndrome X from a psychosomatic point of view. Psychiatr Pol 2008, 42(2):229-236.
6. Chen YX, Luo NS, Lin YQ. Selective estrogen receptor modulators promising for cardiac syndrome X. J Postgrad Med 2010, 56:328-331. 10.4103/0022-3859.70936, 20935411.
7. Cannon RO. Microvascular angina and the continuing dilemma of chest pain with normal coronary angiograms. J Am Coll Cardiol 2009, 54(10):877-885. 10.1016/j.jacc.2009.03.080, 3299059, 19712795.
8. Lamendola P, Tarzia P, Milo M. Coronary microvascular dysfunction: an update. Recenti Progerssi in Medicine 2011, 102(9):329-337.
9. Lanza GA, Colonna G, Pasceri V, Maseri A. Atenolol versus amlodipine versus isosorbide 5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol 1999, 84:854-856. 10.1016/S0002-9149(99)00450-6, 10513787.
10. Crea F, Lanza GA. Angina pectoris and normal coronary arteries. Heart 2004, 90(4):457-463. 10.1136/hrt.2003.020594, 1768150, 15020531.
11. Mao JY, Wang HH, Ge YB. Treatment of cardiac syndrome X by traditional Chinese medicine. Chin J Integr Med On Cardio-/Cerebrovasc Dis 2007, 5(5):377-379.
12. Chen NA, Kam Ming KO. Schisandrin B-induced glutathione antioxidant response and cardioprotection are mediated by reactive oxidant species production in rat hearts. Biol Pharm Bull 2010, 33(5):825-829. 10.1248/bpb.33.825, 20460761.
13. Lujun L, Yue Z, Peng Z, Huifang P, Hanli R. Appraisal of anti-inflammatory and free radical scavenging activities of ethanol extract of Ilex ficoidea Hemsl and Ilex centrochinensis. Environ Toxicol Pharmacol 2011, 32(2):122-127. 10.1016/j.etap.2011.04.003, 21843790.
14. Guo KJ, Xu SF, Yin P. Active components of common traditional Chinese medicine decoctions have antioxidant functions. J Anim Sci 2011, 89(10):3107-3115. 10.2527/jas.2010-3831, 21571894.
15. Huang MH, Wang BS, Chiu CS. Antioxidant, antinociceptive, and anti-inflammatory activities of Xanthii Fructus. J Ethnopharmacol 2011, 135(2):545-552. 10.1016/j.jep.2011.03.057, 21466841.
16. Zhao HY. Research of protection mechanism of compatible radix ophiopogonis, salvia miltiorrhiza and ethyl acetate on apoptosis of vascular endothelial cell (HUVEC). J Nanjing Univ Tradit Chin Med 2010, 244(03):196-198.
17. Hu YF. The influence of different extractives of radix ophiophagous on vascular endothelial cell ICAM-1⊉VEGF⊉Bcl-2 interpretation due to hydrogen peroxide damage. Mod Med Prog 2011, 18:3421-3426.
18. Crea F, Gaetano A, Lanza. Angina pectoris and normalcoronary arteries: cardiac syndrome x. Heart 2004, 90:457-463. 10.1136/hrt.2003.020594, 1768150, 15020531.
19. Kaski JC, Valenzuela Garcia LF. Therapeutic options for the management of patients with cardiac syndrome X. Europe Heart J 2001, 22(4):283-293.
20. International conference on Harmonization Expert Working Group International Conference on Harmonization Guidelines for Good Clinical Practice (ICH-GCP) 1997, http://www.ich.org/products/guidelines/safety/article/safety-guidelines.html, International conference on Harmonization Expert Working Group.
21. Higgins JTP, Green S. Cochrane Handbook for Systematic Reviews of Interventions 2008, Chichester, UK: Wiley Online Library.
22. Geha RS, Schneeberger E, Merler E, Rosen FS. Heterogeneity of acquired or common variable agammaglobulinemia. NEJM 1974, 291:1-6. 10.1056/NEJM197407042910101, 4545549.
23. Sterne JAC, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 2001, 54:1046-1055. 10.1016/S0895-4356(01)00377-8, 11576817.
24. Sun YY, Guo MS. 34 Case report of shenwuguanxinning medicinal granules on CSX patients. Jiangxi Tradit Chin Med J 2007, 11(11):21-22.
25. Ge YL. 19 Case report of Qi and blood nourishing decoction on CSX patients. Shangdong Tradit Chin Med 2011, 30(1):13-14.
26. Peng DG. The effect observation of yindanxinnaotong capsule on CSX. Chin J Integr Tradit West Med Cardiovasc Cerebrovasc Dis Mag 2011, 9(8):746-747.
27. Niu TF, Li J, Xu HX. 30 Cases report of the Xinxuening medicinal granules on CSX. Chin J Integr Tradit West Med Cardiovasc Cerebrovasc Dis Mag 2008, 6(9):1025-1027.
28. Gao AA. 33 Cases report of xiaoyao powder on the female microvascular angina. China's Naturopath 2005, 13(5):33-35.
29. Xu GX, Huang XT. The effect observation of wenxin kernel on CSX. Hubei Tradit Chin Med 2011, 33(4):40-41.
30. Bi XP, Cai XJ, Wei F. The effect observation of tongxinluo capsule on CSX. Hebei Medical Journal 2005, 27(8):587.
31. Wang XL, Mao JY, Wang HH. The clinical research of the kuanxiongliqi decoction on CSX. Shanghai Tradit Chin Med 2009, 43(1):33-35.
32. Xu LJ, Wang WY. The influence of activating blood and removing stasis method on the ET-1 and endothelium-derived relaxation function of CSX patients. The Chin Patient Drug 2002, 24(7):519-521.
33. Liu WJ, Wang ZS. The effect observation of naoxintong on 38 CSX cases. J Shanghai Univ Tradit Chin Med 2008, 9(2):43.
34. Zhang XH, Song QF. 20 cases report of Taohongsiwu decoction on CSX. Chin J TCM Emerg 2002, 11(2):137.
35. Hang LU, Rongrong MA. Clinical observation on the therapeutic effect of Tongxinluo capsule on patients with cardiac X syndrome complicated by abnormality of coronary artery flow reserve. Chin J Diffic and Compl Cas 2007, 6(11):655-657.
36. Xiaohong Z, Yanping J. Clinical observation of decoction for removing blood stasis in the treatment of 37 cases of X syndrome. J Hennan Univ Chin Med 2003, 18(2):59.
37. Liang C, Xiao S, Yusheng REN, Chengbo SUN, Zonggui WU. Effect of Lei 's danshen tablets on treatment and the level of C-reaction protein in patients with cardiac syndrome X. Chin Patient Drug 2007, 1:21-23.
38. Yuan J, Wang Q. Clinical effect observation of danhong injection on CSX. J Emerg Tradit Chin Med 2008, 17(10):1339-1340.
39. Wang G, Cao Y. Clinical observation on 18 cases of cardiac X-syndrome treated by guanmailing prescription. Hunan J Tradit Chin Med 2008, 24(2):1-3.
40. Zhang S, Ni J, Wei S. Clinical effect observation of guanmaining prescription on CSX. Modern J Integr Tradit Chin West Med 2008, 17(10):1511.
41. Zhang X. 48 Cases report of soothing the liver and regulating Qi method on CSX. J Emerg Tradit Chin Med 2008, 17(11):1608-1609.
42. Wu L, Sun J, Wang C. The clinical study of cardiac X- syndrome treated with shuxuening parenteral solution. Chin J Integr Med Cardio-/Cerebrovasc Dis 2010, 8(6):652-653.
43. Shuyan LI, Qi T. 36 Cases report of the tongxinluo capsule combined with western medicine on CSX. Yunan Tradit Chin Med 2009, 30(11):15-16.
44. Zhanbin P, Chongming LI, Cheng R, Yuan B. Clinical study of tongxinluo capsule on CSX. J Bethune Military Med College 2005, 3(1):25-26.
45. Meeting for treatment and prevention of angina of coronary heart disease and arrhythmia by integrated western and Chinese medicine; efficacy criteria for angina of coronary heart disease. J Tradit Chin Med 1996, 16(10):583.
46. Zheng YY. Guidelines for clinical research of Chinese medicine (New drugs) 2002, 68-73. Beijing: Chinese Medicine and Science Publication House, 2.
47. Marshall AJ, Hutchings F, James AJ, Kelion AD. Prognostic value of a nine-minute treadmill test in patients undergoing myocardial perfusion scintigraphy. Am J Cardiol 2010, 106(10):1423-1428. 10.1016/j.amjcard.2010.06.074, 21059431.